Role of macrophages in HIV infection and persistence

References

• Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med.338(13), 853–860 (1998).
   PubMed Web of Science ®Google Scholar
• Simon V, Ho DD. HIV-1 dynamics in vivo: implications for therapy. Nat. Rev. Microbiol.1(3), 181–190 (2003).
   PubMed Web of Science ®Google Scholar
• Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med.8(4), 319–323 (2002).
   PubMed Web of Science ®Google Scholar
• Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev.57(1), 183–289 (1993).
   PubMedGoogle Scholar
• Chernyak L, Tauber AI. The birth of immunology: Metchnikoff, the embryologist. Cell. Immunol.117(1), 218–233 (1988).
   PubMed Web of Science ®Google Scholar
• van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J. Exp. Med.128(3), 415–435 (1968).
   PubMed Web of Science ®Google Scholar
• Gordon S. The role of the macrophage in immune regulation. Res. Immunol.149(7–8), 685–688 (1998).
   PubMedGoogle Scholar
• Hume DA, Ross IL, Himes SR et al. The mononuclear phagocyte system revisited. J. Leukoc. Biol.72(4), 621–627 (2002).
   PubMed Web of Science ®Google Scholar
• Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell124(4), 823–835 (2006).
   PubMed Web of Science ®Google Scholar
• Unanue ER, Allen PM. Biochemistry and biology of antigen presentation by macrophages. Cell. Immunol.99(1), 3–6 (1986).
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol.5(12), 953–964 (2005).
   PubMed Web of Science ®Google Scholar
• van Furth R. Monocyte production during inflammation. Comp. Immunol. Microbiol. Infect. Dis.8(2), 205–211 (1985).
   PubMed Web of Science ®Google Scholar
• Weber C, Belge KU, von Hundelshausen P et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol.67(5), 699–704 (2000).
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock HW, Fingerle G, Strobel M et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol.23(9), 2053–2058 (1993).
   PubMed Web of Science ®Google Scholar
• de Groot CJ, Huppes W, Sminia T, Kraal G, Dijkstra CD. Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. Glia6(4), 301–309 (1992).
   PubMed Web of Science ®Google Scholar
• Clapham PR, McKnight A. HIV-1 receptors and cell tropism. Br. Med. Bull.58, 43–59 (2001).
   PubMed Web of Science ®Google Scholar
• Verani A, Gras G, Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol.42(2), 195–212 (2005).
   PubMed Web of Science ®Google Scholar
• Schmidtmayerova H, Alfano M, Nuovo G, Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol.72(6), 4633–4642 (1998).
   PubMed Web of Science ®Google Scholar
• Yi Y, Rana S, Turner JD, Gaddis N, Collman RG. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol.72(1), 772–777 (1998).
   PubMed Web of Science ®Google Scholar
• Lapham CK, Zaitseva MB, Lee S, Romanstseva T, Golding H. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat. Med.5(3), 303–308 (1999).
   PubMed Web of Science ®Google Scholar
• Simmons G, Reeves JD, McKnight A et al. CXCR4 as a functional co-receptor for human immunodeficiency virus type 1 infection of primary macrophages. J. Virol.72(10), 8453–8457 (1998).
   PubMed Web of Science ®Google Scholar
• Verani A, Pesenti E, Polo S et al. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J. Immunol.161(5), 2084–2088 (1998).
   PubMed Web of Science ®Google Scholar
• Yi Y, Isaacs SN, Williams DA et al. Role of CXCR4 in cell–cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J. Virol.73(9), 7117–7125 (1999).
   PubMed Web of Science ®Google Scholar
• Yi Y, Chen W, Frank I et al. An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis. J. Neurovirol.9(4), 432–441 (2003).
   PubMed Web of Science ®Google Scholar
• Jayakumar P, Berger I, Autschbach F et al. Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. J. Virol.79(8), 5220–5226 (2005).
   PubMed Web of Science ®Google Scholar
• Gorry PR, Bristol G, Zack JA et al. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of co-receptor specificity. J. Virol.75(21), 10073–10089 (2001).
   PubMed Web of Science ®Google Scholar
• Briggs DR, Tuttle DL, Sleasman JW, Goodenow MM. Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). AIDS14(18), 2937–2939 (2000).
   PubMed Web of Science ®Google Scholar
• Ghaffari G, Tuttle DL, Briggs D et al. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. J. Virol.79(21), 13250–13261 (2005).
   PubMed Web of Science ®Google Scholar
• Marechal V, Prevost MC, Petit C et al. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol.75(22), 11166–11177 (2001).
   PubMed Web of Science ®Google Scholar
• Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol.33(2), 483–493 (2003).
   PubMed Web of Science ®Google Scholar
• Mondor I, Ugolini S, Sattentau QJ. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol.72(5), 3623–3634 (1998).
   PubMed Web of Science ®Google Scholar
• Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol.75(19), 9187–9200 (2001).
   PubMed Web of Science ®Google Scholar
• Lafrenie RM, Lee SF, Hewlett IK, Yamada KM, Dhawan S. Involvement of integrin αvβ3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes. Virology297(1), 31–38 (2002).
   PubMed Web of Science ®Google Scholar
• Montefiori DC. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection. Springer Semin. Immunopathol.18(3), 371–390 (1997).
   PubMed Web of Science ®Google Scholar
• Ma G, Greenwell-Wild T, Lei K et al. Secretory leukocyte protease inhibitor binds to annexin II, a co-factor for macrophage HIV-1 infection. J. Exp. Med.200(10), 1337–1346 (2004).
   PubMed Web of Science ®Google Scholar
• von Lindern JJ, Rojo D, Grovit-Ferbas K et al. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol.77(6), 3624–3633 (2003).
   PubMed Web of Science ®Google Scholar
• Collin M, Gordon S. The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology200(1), 114–120 (1994).
   PubMed Web of Science ®Google Scholar
• O’Brien WA, Namazi A, Kalhor H et al. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol.68(2), 1258–1263 (1994).
   PubMed Web of Science ®Google Scholar
• Diamond TL, Roshal M, Jamburuthugoda VK et al. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem.279(49), 51545–51553 (2004).
   PubMed Web of Science ®Google Scholar
• Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle. J. Biol. Chem.30, 30 (2005).
   Google Scholar
• McDonald D, Vodicka MA, Lucero G et al. Visualization of the intracellular behavior of HIV in living cells. J. Cell. Biol.159(3), 441–452 (2002).
   PubMed Web of Science ®Google Scholar
• Bukrinsky M. A hard way to the nucleus. Mol. Med.10(1–6), 1–5 (2004).
   PubMed Web of Science ®Google Scholar
• Zennou V, Petit C, Guetard D et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell101(2), 173–185 (2000).
   PubMed Web of Science ®Google Scholar
• Yamashita M, Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog.1(3), E18 (2005).
   PubMed Web of Science ®Google Scholar
• Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J.22(14), 3675–3685 (2003).
   PubMed Web of Science ®Google Scholar
• Zielske SP, Stevenson M. Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J. Virol.79(17), 11541–11546 (2005).
   PubMed Web of Science ®Google Scholar
• Jacque JM, Stevenson M. The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature441(7093), 641–645 (2006).
   PubMed Web of Science ®Google Scholar
• Gillim-Ross L, Cara A, Klotman ME. HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages. Viral Immunol.18(1), 190–196 (2005).
   PubMed Web of Science ®Google Scholar
• Liou LY, Herrmann CH, Rice AP. HIV-1 infection and regulation of Tat function in macrophages. Int. J. Biochem. Cell. Biol.36(9), 1767–1775 (2004).
   PubMed Web of Science ®Google Scholar
• Rohr O, Marban C, Aunis D, Schaeffer E. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukoc. Biol.74(5), 736–749 (2003).
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Calame KL. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl Acad. Sci. USA94(16), 8714–8719 (1997).
   PubMed Web of Science ®Google Scholar
• Lee ES, Kalantari P, Tsutsui Section S et al. RON receptor tyrosine kinase, a negative regulator of inflammation, inhibits HIV-1 transcription in monocytes/macrophages and is decreased in brain tissue from patients with AIDS. J. Immunol.173(11), 6864–6872 (2004).
   PubMed Web of Science ®Google Scholar
• Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA,98(24), 13925–13930 (2001).
   PubMed Web of Science ®Google Scholar
• Brugger B, Glass B, Haberkant P et al. The HIV lipidome: a raft with an unusual composition. Proc. Natl Acad. Sci. USA15, 15 (2006).
   Google Scholar
• Orenstein JM, Meltzer MS, Phipps T, Gendelman HE. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J. Virol.62(8), 2578–2586 (1988).
   PubMed Web of Science ®Google Scholar
• Raposo G, Moore M, Innes D et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic3(10), 718–729 (2002).
   PubMed Web of Science ®Google Scholar
• Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell. Biol.162(3), 443–455 (2003).
   PubMed Web of Science ®Google Scholar
• Kramer B, Pelchen-Matthews A, Deneka M et al. HIV interaction with endosomes in macrophages and dendritic cells. Blood Cells Mol. Dis.35(2), 136–142 (2005).
   PubMed Web of Science ®Google Scholar
• van’t Wout AB, Kootstra NA, Mulder-Kampinga GA et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest.94(5), 2060–2067 (1994).
   PubMed Web of Science ®Google Scholar
• Schacker T, Little S, Connick E et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis.183(4), 555–562 (2001).
   PubMed Web of Science ®Google Scholar
• Spira AI, Marx PA, Patterson BK et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med.183(1), 215–225 (1996).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science286(5443), 1353–1357 (1999).
   PubMed Web of Science ®Google Scholar
• Smith PD, Meng G, Salazar-Gonzalez JF, Shaw GM. Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol.74(5), 642–649 (2003).
   PubMed Web of Science ®Google Scholar
• Wahl SM, Greenwell-Wild T, Peng G et al. Viral and host cofactors facilitate HIV-1 replication in macrophages. J. Leukoc. Biol.74(5), 726–735 (2003).
   PubMed Web of Science ®Google Scholar
• Kawamura T, Kurtz SE, Blauvelt A, Shimada S. The role of Langerhans cells in the sexual transmission of HIV. J. Dermatol. Sci.40(3), 147–155 (2005).
   PubMed Web of Science ®Google Scholar
• Goodenow MM, Rose SL, Tuttle DL, Sleasman JW. HIV-1 fitness and macrophages. J. Leukoc. Biol.74(5), 657–666 (2003).
   PubMed Web of Science ®Google Scholar
• Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol.74(5), 635–641 (2003).
   PubMed Web of Science ®Google Scholar
• Eckstein DA, Sherman MP, Penn ML et al. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J. Exp. Med.194(10), 1407–1419 (2001).
   PubMed Web of Science ®Google Scholar
• Igarashi T, Brown CR, Endo Y et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl Acad. Sci. USA98(2), 658–663 (2001).
   PubMed Web of Science ®Google Scholar
• Imamichi H, Igarashi T, Imamichi T et al. Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic. Proc. Natl Acad. Sci. USA99(21), 13813–13818 (2002).
   PubMed Web of Science ®Google Scholar
• Igarashi T, Donau OK, Imamichi H et al. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages. J. Virol.77(24), 13042–13052 (2003).
   PubMed Web of Science ®Google Scholar
• Garaci E, Aquaro S, Lapenta C et al. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Proc. Natl Acad. Sci. USA100(15), 8927–8932 (2003).
   PubMed Web of Science ®Google Scholar
• Gorry PR, Sterjovski J, Churchill M et al. The role of viral co-receptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression. Sex. Health1(1), 23–34 (2004).
   PubMedGoogle Scholar
• Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science276(5320), 1857–1861 (1997).
   PubMed Web of Science ®Google Scholar
• Zhao C, Papadopoulou B, Tremblay MJ. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin. Immunol.113(1), 81–88 (2004).
   PubMed Web of Science ®Google Scholar
• Stevenson M. HIV-1 pathogenesis. Nat. Med.9(7), 853–860 (2003).
   PubMed Web of Science ®Google Scholar
• Swingler S, Mann A, Jacque J et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med.5(9), 997–1003 (1999).
   PubMed Web of Science ®Google Scholar
• Swingler S, Brichacek B, Jacque JM et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature424(6945), 213–219 (2003).
   PubMed Web of Science ®Google Scholar
• Sharova N, Swingler C, Sharkey M, Stevenson M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J.24(13), 2481–2489 (2005).
   PubMed Web of Science ®Google Scholar
• Herbein G, Mahlknecht U, Batliwalla F et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature395(6698), 189–194 (1998).
   PubMed Web of Science ®Google Scholar
• Badley AD, Dockrell D, Simpson M et al. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med.185(1), 55–64 (1997).
   PubMed Web of Science ®Google Scholar
• Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood98(6), 1667–1677 (2001).
   PubMed Web of Science ®Google Scholar
• Kedzierska K, Azzam R, Ellery P et al. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol.26(2), 247–263 (2003).
   PubMed Web of Science ®Google Scholar
• Pugliese A, Vidotto V, Beltramo T, Torre D. Phagocytic activity in human immunodeficiency virus type 1 infection. Clin. Diagn. Lab. Immunol.12(8), 889–895 (2005).
   PubMedGoogle Scholar
• Jaworowski A, Ellery P, Maslin CL et al. Normal CD16 expression and phagocytosis of mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients. J. Infect. Dis.193(5), 693–697 (2006).
   PubMed Web of Science ®Google Scholar
• Vazquez N, Greenwell-Wild T, Marinos NJ et al. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol.79(7), 4479–4491 (2005).
   PubMed Web of Science ®Google Scholar
• Orenstein JM. The macrophage in HIV infection. Immunobiology204(5), 598–602 (2001).
   PubMed Web of Science ®Google Scholar
• Tyner JW, Uchida O, Kajiwara N et al. CCL5–CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med.11(11), 1180–1187 (2005).
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Gendelman HE. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J. Leukoc. Biol.74(5), 691–701 (2003).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol.5(1), 69–81 (2005).
   PubMed Web of Science ®Google Scholar
• Pereira CF, Paridaen JT. Anti-HIV drug development – an overview. Curr. Pharm. Des.10(32), 4005–4037 (2004).
   PubMed Web of Science ®Google Scholar
• Chun TW, Davey RT Jr, Ostrowski M et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med.6(7), 757–761 (2000).
   PubMed Web of Science ®Google Scholar
• Garbuglia AR, Calcaterra S, D’Offizi G et al. HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption. J. Med. Virol.74(3), 373–381 (2004).
   PubMed Web of Science ®Google Scholar
• Schrager LK, D’Souza MP. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA280(1), 67–71 (1998).
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell100(5), 587–597 (2000).
   PubMed Web of Science ®Google Scholar
• Burleigh L, Lozach PY, Schiffer C et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol.80(6), 2949–2957 (2006).
   PubMed Web of Science ®Google Scholar
• Nobile C, Petit C, Moris A et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol.79(9), 5386–5399 (2005).
   PubMed Web of Science ®Google Scholar
• Smythies LE, Sellers M, Clements RH et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest.115(1), 66–75 (2005).
   PubMed Web of Science ®Google Scholar
• Shikuma CM, Valcour VG, Ratto-Kim S et al. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages? Clin. Infect. Dis.40(12), 1846–1848 (2005).
   PubMed Web of Science ®Google Scholar
• Medeiros RP, Munerato P, Diaz RS. HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy. J. Clin. Virol.30(4), 346–347 (2004).
   PubMed Web of Science ®Google Scholar
• Blankson JN, Finzi D, Pierson TC et al. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J. Infect. Dis.182(6), 1636–1642 (2000).
   PubMed Web of Science ®Google Scholar
• Haggerty S, Stevenson M. Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol.4(2), 123–131 (1991).
   PubMedGoogle Scholar
• Wong JK, Ignacio CC, Torriani F et al. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J. Virol.71(3), 2059–2071 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang L, Rowe L, He T et al. Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection. J. Virol.76(18), 9465–9473 (2002).
   PubMed Web of Science ®Google Scholar
• Fulcher JA, Hwangbo Y, Zioni R et al. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection. J. Virol.78(15), 7883–7893 (2004).
   PubMed Web of Science ®Google Scholar
• Delobel P, Sandres-Saune K, Cazabat M et al. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS19(16), 1739–1750 (2005).
   PubMed Web of Science ®Google Scholar
• Thompson KA, Churchill MJ, Gorry PR et al. Astrocyte specific viral strains in HIV dementia. Ann. Neurol.56(6), 873–877 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang L, Chung C, Hu BS et al. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Invest.106(7), 839–845 (2000).
   PubMed Web of Science ®Google Scholar
• Garbuglia AR, Zaccarelli M, Calcaterra S et al. Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): high viral burden in macrophages after 1 year of treatment. J. Chemother.13(2), 188–194 (2001).
   PubMed Web of Science ®Google Scholar
• Perno CF, Balestra E, Francesconi M et al. Antiviral profile of HIV inhibitors in macrophages: implications for therapy. Curr. Top. Med. Chem.4(9), 1009–1015 (2004).
   PubMed Web of Science ®Google Scholar
• Aquaro S, Bagnarelli P, Guenci T et al. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J. Med. Virol.68(4), 479–488 (2002).
   PubMed Web of Science ®Google Scholar
• Perno CF, Newcomb FM, Davis DA et al. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J. Infect. Dis.178(2), 413–422 (1998).
   PubMed Web of Science ®Google Scholar
• Jong A, Huang SH. Blood–brain barrier drug discovery for central nervous system infections. Curr. Drug Targets Infect. Disord.5(1), 65–72 (2005).
   PubMedGoogle Scholar
• Owen A, Chandler B, Back DJ. The implications of P-glycoprotein in HIV: friend or foe? Fundam. Clin. Pharmacol.19(3), 283–296 (2005).
   PubMed Web of Science ®Google Scholar
• Ghosn J, Chaix ML, Peytavin G et al. Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. AIDS18(14), 1958–1961 (2004).
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Siliciano RF. A long-term latent reservoir for HIV-1: discovery and clinical implications. J. Antimicrob. Chemother.54(1), 6–9 (2004).
   PubMed Web of Science ®Google Scholar
• Chun TW, Fauci AS. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl Acad. Sci. USA96(20), 10958–10961 (1999).
   PubMed Web of Science ®Google Scholar
• Lehrman G, Hogue IB, Palmer S et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet366(9485), 549–555 (2005).
   PubMed Web of Science ®Google Scholar
• Magnani M, Balestra E, Fraternale A et al. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. J. Leukoc. Biol.74(5), 764–771 (2003).
   PubMed Web of Science ®Google Scholar
• Potula R, Poluektova L, Knipe B et al. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood106(7), 2382–2390 (2005).
   PubMed Web of Science ®Google Scholar
• Mebatsion T, Finke S, Weiland F, Conzelmann KK. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell90(5), 841–847 (1997).
   PubMed Web of Science ®Google Scholar
• Peretti S, Schiavoni I, Pugliese K, Federico M. Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles. Virology345(1), 115–126 (2006).
   PubMed Web of Science ®Google Scholar
• Keppler OT, Welte FJ, Ngo TA et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med.195(6), 719–736 (2002).
   PubMed Web of Science ®Google Scholar
• Nathwani AC, Davidoff AM, Linch DC. A review of gene therapy for haematological disorders. Br. J. Haematol.128(1), 3–17 (2005).
   PubMed Web of Science ®Google Scholar